![Martina Banyay](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Martina Banyay
Vorstandsvorsitzender bei VivoLogica AB
Aktive Positionen von Martina Banyay
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
VivoLogica AB
![]() VivoLogica AB Packaged SoftwareTechnology Services VivoLogica AB specializes in providing a comprehensive tool for data collection, analysis, compliance, and reporting for research purposes. The company is based in Stockholm, Sweden. The Swedish company offers a platform that enables researchers to have full control over their research data and provides scientific output in one tool. The company was founded by Sara Mangsbo, and the CEO is Martina Banyay. | Vorstandsvorsitzender | - | - |
Karriereverlauf von Martina Banyay
Ehemalige bekannte Positionen von Martina Banyay
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ZICCUM AB | Direktor/Vorstandsmitglied | - | - |
Atlas Antibodies AB
![]() Atlas Antibodies AB BiotechnologyHealth Technology Atlas Antibodies AB develops antibodies and reagents for Mass Spectrometry (MS)-based quantitative proteomics. Its project Human Protein Atlas aim to present an expression map of the complete human proteome. It offers characterized antibodies to various protein coding human genes; Triple A Polyclonals that are research grade rabbit polyclonal antibodies; and mouse monoclonal antibodies to selected proteins, as a complement to rabbit polyclonal antibodies. Its antibodies are used to study human proteins, for basic research purposes and clinical research in various disease areas, such as cancer and neurological brain diseases. The company was founded by Jan Fredrik Pontén, Karin Marianne Hansson, Henrik Wernérus, and Carl Erik Mathias Uhlén in 2006 and is headquartered in Stockholm, Sweden. | Geschäftsführer | 01.01.2009 | - |
Ausbildung von Martina Banyay
University of Stockholm | Doctorate Degree |
Statistik
International
Schweden | 5 |
Operativ
Chief Operating Officer | 1 |
Doctorate Degree | 1 |
Chief Executive Officer | 1 |
Sektoral
Health Technology | 3 |
Consumer Services | 2 |
Technology Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
ZICCUM AB | Health Technology |
Private Unternehmen | 2 |
---|---|
Atlas Antibodies AB
![]() Atlas Antibodies AB BiotechnologyHealth Technology Atlas Antibodies AB develops antibodies and reagents for Mass Spectrometry (MS)-based quantitative proteomics. Its project Human Protein Atlas aim to present an expression map of the complete human proteome. It offers characterized antibodies to various protein coding human genes; Triple A Polyclonals that are research grade rabbit polyclonal antibodies; and mouse monoclonal antibodies to selected proteins, as a complement to rabbit polyclonal antibodies. Its antibodies are used to study human proteins, for basic research purposes and clinical research in various disease areas, such as cancer and neurological brain diseases. The company was founded by Jan Fredrik Pontén, Karin Marianne Hansson, Henrik Wernérus, and Carl Erik Mathias Uhlén in 2006 and is headquartered in Stockholm, Sweden. | Health Technology |
VivoLogica AB
![]() VivoLogica AB Packaged SoftwareTechnology Services VivoLogica AB specializes in providing a comprehensive tool for data collection, analysis, compliance, and reporting for research purposes. The company is based in Stockholm, Sweden. The Swedish company offers a platform that enables researchers to have full control over their research data and provides scientific output in one tool. The company was founded by Sara Mangsbo, and the CEO is Martina Banyay. | Technology Services |
- Börse
- Insiders
- Martina Banyay
- Erfahrung